Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Samulski

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
Human Gene Therapy|March 21, 2000
The use of adeno-associated virus to circumvent the maturation-dependent viral transduction of muscle fibersR Pruchnic, B Cao, Z Q Peterson, et al.
Hepatology (Baltimore, Md.)|October 26, 2000
Chronic ethanol increases adeno-associated viral transgene expression in rat liver via oxidant and NFkappaB-dependent mechanismsM D Wheeler, H Kono, I Rusyn, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|December 23, 2018
Genetic modification of scAAV-equine-BMP-2 transduced bone-marrow-derived mesenchymal stem cells before and after cryopreservation: An "off-the-shelf" option for fracture repairAlyssa N Ball, Jennifer N Phillips, C Wayne McIlwraith, et al.
Nature Genetics|October 1, 1994
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brainM G Kaplitt, P Leone, R J Samulski, et al.
Gene Therapy|September 16, 2016
Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropismS K Powell, N Khan, C L Parker, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 7, 2007
Optimization of self-complementary AAV vectors for liver-directed expression results in sustained correction of hemophilia B at low vector doseZhijian Wu, Junjiang Sun, Taiping Zhang, et al.
Gene Therapy|March 10, 2012
Three-dimensional multipotent progenitor cell aggregates for expansion, osteogenic differentiation and 'in vivo' tracing with AAV vector serotype 6J R Ferreira, M L Hirsch, L Zhang, et al.
Gene Therapy|April 24, 2015
scAAVIL-1ra dosing trial in a large animal model and validation of long-term expression with repeat administration for osteoarthritis therapyL R Goodrich, J C Grieger, J N Phillips, et al.
Gene Therapy|August 24, 1999
Recombinant adeno-associated virus purification using novel methods improves infectious titer and yieldS Zolotukhin, B J Byrne, E Mason, et al.
Human Gene Therapy|January 10, 2002
Comparison of the effect of adenoviral delivery of three superoxide dismutase genes against hepatic ischemia-reperfusion injuryM D Wheeler, M Katuna, O M Smutney, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Human Gene Therapy|March 21, 2000
The use of adeno-associated virus to circumvent the maturation-dependent viral transduction of muscle fibersR Pruchnic, B Cao, Z Q Peterson, et al.
Hepatology (Baltimore, Md.)|October 26, 2000
Chronic ethanol increases adeno-associated viral transgene expression in rat liver via oxidant and NFkappaB-dependent mechanismsM D Wheeler, H Kono, I Rusyn, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|December 23, 2018
Genetic modification of scAAV-equine-BMP-2 transduced bone-marrow-derived mesenchymal stem cells before and after cryopreservation: An "off-the-shelf" option for fracture repairAlyssa N Ball, Jennifer N Phillips, C Wayne McIlwraith, et al.
Nature Genetics|October 1, 1994
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brainM G Kaplitt, P Leone, R J Samulski, et al.
Gene Therapy|September 16, 2016
Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropismS K Powell, N Khan, C L Parker, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 7, 2007
Optimization of self-complementary AAV vectors for liver-directed expression results in sustained correction of hemophilia B at low vector doseZhijian Wu, Junjiang Sun, Taiping Zhang, et al.
Gene Therapy|March 10, 2012
Three-dimensional multipotent progenitor cell aggregates for expansion, osteogenic differentiation and 'in vivo' tracing with AAV vector serotype 6J R Ferreira, M L Hirsch, L Zhang, et al.
Gene Therapy|April 24, 2015
scAAVIL-1ra dosing trial in a large animal model and validation of long-term expression with repeat administration for osteoarthritis therapyL R Goodrich, J C Grieger, J N Phillips, et al.
Gene Therapy|August 24, 1999
Recombinant adeno-associated virus purification using novel methods improves infectious titer and yieldS Zolotukhin, B J Byrne, E Mason, et al.
Human Gene Therapy|January 10, 2002
Comparison of the effect of adenoviral delivery of three superoxide dismutase genes against hepatic ischemia-reperfusion injuryM D Wheeler, M Katuna, O M Smutney, et al.
Pageof 13